T h e n e w e ngl a nd j o u r na l o f m e dic i n e. clinical problem-solving

Size: px
Start display at page:

Download "T h e n e w e ngl a nd j o u r na l o f m e dic i n e. clinical problem-solving"

Transcription

1 T h e n e w e ngl a nd j o u r na l o f m e dic i n e clinical problem-solving Skin Deep Nasia Safdar, M.D., Ph.D., Cybele L. Abad, M.D., Daniel R. Kaul, M.D., and Sanjay Saint, M.D., M.P.H. In this Journal feature, information about a real patient is presented in stages (boldface type) to an expert clinician, who responds to the information, sharing his or her reasoning with the reader (regular type). The authors commentary follows. From the Department of Medicine, University of Wisconsin Madison School of Medicine, Madison (N.S.); the Early Intervention Program Clinic, Milwaukee Health Services, Milwaukee (C.L.A.); and the Department of Internal Medicine, University of Michigan Medical School (D.R.K., S.S.), and the Department of Veterans Affairs Health Services Research and Development Center of Excellence (S.S.) both in Ann Arbor. Address reprint requests to Dr. Safdar at the University of Wisconsin Madison, MFCB 5221, 1685 Highland Ave., Madison, WI 53705, or at ns2@medicine.wisc.edu. This article ( /NEJMcps ) was updated on September 6, 2012, at NEJM.org. N Engl J Med 2012;366: Copyright 2012 Massachusetts Medical Society. A 56-year-old woman with symptoms of carpal tunnel syndrome for 6 months presented to a referral clinic with nodular lesions on her right forearm and hand that had appeared 4 months before consultation. The lesions were associated with an increase in numbness and tingling in her right hand. She reported no weight loss, fever, chills, headaches, rashes, myalgias, or arthralgias. She did, however, describe intermittent night sweats. The differential diagnosis of chronic nodular lesions is broad and includes infectious, inflammatory, and malignant causes. Common infectious causes include fungal and mycobacterial infections and nocardiosis. The history taking should include an assessment for potential exposures. For example, gardeners are at risk for sporotrichosis and nocardiosis, whereas tropical-fish owners who clean the aquarium may become infected with Mycobacterium marinum. Certain infections, such as leishmaniasis, myiasis, and visceral larva migrans, are associated with travel to particular geographic areas. Inflammatory causes of nodules include lupus erythematosus profundus and cutaneous polyarteritis. During the previous 3 months, the patient had several appointments with an orthopedic surgeon for carpal tunnel syndrome. The surgeon performed an incision and drainage on one of the forearm lesions, and serosanguineous fluid was noted. No cultures were sent. Over the next 2 weeks, new lesions formed on the dorsum of her hand and on the palmar side at the base of the middle finger. A carpal-tunnel release procedure was then performed on the right side; biopsy specimens of the lesions on her hand and forearm were obtained during the procedure. Pathological assessment of these biopsy specimens revealed granulomas with central necrosis and predominant neutrophilic infiltration. Gram s stain and special stains were negative for bacteria, mycobacteria, and fungi. Cultures for all these organisms remained negative. The numbness and tingling in her arm persisted despite the release procedure, and new cutaneous lesions continued to develop. Eight weeks after the carpal-tunnel release, the patient was referred to an academic medical center. The finding of suppurative granulomas is helpful in narrowing the differential diagnosis. Fungal and mycobacterial infections are the most common cause. Negative cultures and special stains raise the possibility of cutaneous tuberculosis; papulonecrotic tuberculids may have very few organisms. A chest radiograph and tuberculin skin test should be performed. Polymerase-chain-reaction assays for fungal, mycobacterial, and bacterial DNA on tissue (fresh-frozen or paraffin-embedded) may also be useful but are not widely available. Some cutaneous inflammatory conditions (e.g., drug-induced vasculitis, systemic lupus erythematosus, Sjögren s syndrome, rheumatoid arthritis, scleroderma, or dermatomyositis) and lymphoma may also result 1336

2 in granuloma formation. I am very interested in the patient s exposure and occupational history. The patient s medical history was also notable for temporomandibular joint syndrome, anxiety, allergic rhinitis, and a long-standing heart murmur. She had annual tuberculin skin tests at her job at a medical clinic; after 13 years of negative tests, her most recent test 3 weeks earlier was positive, with 11 mm of induration; a chest radiograph was negative. Isoniazid was prescribed for latent tuberculosis. Her other medications included pyridoxine, alprazolam, escitalopram, conjugated estrogen and progestin, and folic acid. The patient lived in the midwestern United States. She did not smoke and drank alcohol occasionally. She had no pets. She worked in a medical-records department but had no exposure to patients, and she was also a professional hairdresser. Her only recent travel was to Florida a year before her symptoms appeared, where she spent time on a beach collecting shells. She recalled injuring her thumb on a thorn on a separate occasion approximately 4 months before the nodular lesions appeared, and had pain and erythema that persisted for 4 weeks but then completely resolved without treatment. The recent tuberculin-skin-test conversion, combined with the finding of granulomas, is suggestive of a cutaneous mycobacterial infection. Infection with atypical mycobacteria, as could have occurred with the patient s thorn injury, could also cause tuberculin-skin-test conversion. An interferon-γ release assay (IGRA) should be performed, because this assay has less cross-reactivity with atypical mycobacteria, and a negative result would be helpful in narrowing the differential diagnosis. In any case, a thorough search for an underlying focus of tuberculosis (e.g., a careful history taking and physical examination, complete blood count, chest radiograph, and urinalysis) is mandatory. To prevent the emergence of drug resistance, the isoniazid should be discontinued until active tuberculosis can be ruled out. The thorn injury might also be a source of infection with nocardia or fungi such as sporothrix. On physical examination, the patient did not appear to be in distress and was alert and oriented. The temperature was 37 C, and lungs were clear on auscultation bilaterally. Cardiovascular examination revealed distinct heart sounds, regular rhythm, and a grade 2/6 systolic murmur radiating to the axilla. The abdomen was soft and nontender. The volar aspect of her right arm had a 6-cm surgical incision, with a violaceous area surrounding it. There was induration but no warmth or tenderness. The dorsal aspect of the arm was swollen from the hand to midway up the forearm. There were also multiple small, nodular lesions scattered on the dorsal surface of the hand, wrist, and forearm (Fig. 1). These lesions were nontender, and no discharge could be expressed. On the palm, there was scarring from the carpal-tunnel repair, along the thenar eminence. There was a firm, papulonodular lesion at the base of the right middle finger, which was erythematous and nontender. The patient held her right hand in a flexed position, and both active and passive movement of the right hand and wrist was painful. Examination of her left hand and other extremities showed no abnormalities. I am concerned that the swelling may indicate infectious tenosynovitis, which may be caused by bacteria (e.g., Neisseria gonorrhoeae or Staphylococcus aureus), endemic fungi, or mycobacteria. The most likely diagnoses in this case remain a mycobacterial infection (tuberculosis or an atypical mycobacterial infection), an endemic fungal infection, and nocardiosis. An accurate diagnosis is critical for successful treatment, and it may be necessary to perform a repeat biopsy of one of the nodular lesions, with special stains and cultures and histopathological analysis of the biopsy specimen, as well as a polymerase-chain-reaction assay, if available. The white-cell count was 4600 per cubic millimeter, with 55% neutrophils, 43% lymphocytes, and 2% monocytes. The hematocrit was 36%, and the platelet count 170,000 per cubic millimeter. Liverfunction tests were normal. The creatinine level was 0.7 mg per deciliter (61.9 µmol per liter). The results of an electrolyte panel, including the calcium level, and urinalysis were normal. The erythrocyte sedimentation rate was 10 mm per hour, and the C-reactive protein level was 1 mg per deciliter. A chest radiograph was normal. The results of the laboratory tests do not help differentiate among the infections previously discussed. Low levels of inflammatory markers and a normal white-cell count are typical findings in patients with localized chronic lesions of this type. 1337

3 T h e n e w e ngl a nd j o u r na l o f m e dic i n e The MRI scan suggests extensive disease. In retrospect, it is likely that the cause of her carpal-tunnel symptoms was encasement of nerves by the infectious process. Staining for acid-fast bacilli was positive (Fig. 3). A QuantiFERON TB Gold (QFT) test (Cellestis) was negative, and isoniazid was discontinued. Given the negative QFT test, M. tuberculosis is unlikely, and I agree with discontinuation of the isoniazid. A number of nontuberculous mycobacterial species, many of which have specific temperature and growth requirements, may cause skin and soft-tissue infections. Figure 1. Cutaneous Lesions on the Patient s Right Hand. Four nodular lesions (arrows), with surrounding erythema, are shown on the dorsal surface of the patient s right hand. A repeat biopsy was performed on one of the skin lesions. Pathological analysis of the biopsy specimen revealed fibrosis and a patchy, mixed inflammatory infiltrate. Stains for bacteria, fungi, and acid-fast bacilli were negative; cultures were performed. The pathological findings have not clearly revealed a cancer, and the patient does not have any other findings suggestive of an inflammatory disease. Given the tuberculin-skin-test conversion, I remain concerned that she has cutaneous tuberculosis, since the yield on culture and acid-fast bacilli staining may be low. Pending mycobacterial culture results, if there is clinical worsening, I would recommend collection of additional biopsy specimens from one or more of the nodules to help establish the diagnosis. Because of worsening pain and increased limitation in wrist function, magnetic resonance imaging (MRI) of the patient s right arm was performed. This showed extensive tenosynovitis in all the tendons of the forearm and a soft-tissue collection around the forearm (Fig. 2). The patient underwent explorative surgery, and several large-volume specimens from the soft-tissue collection were obtained for staining and additional cultures. A culture for acid-fast bacilli was positive for M. marinum after 4 weeks. Treatment with clarithromycin and ethambutol was started. At a follow-up visit 3 months later, the lesions showed improvement. By the time the patient had completed antimycobacterial therapy, 9 months after the start of treatment, the nodules and all symptoms had resolved. Commen ta r y M. marinum, a well-described cause of cutaneous infections, can lead to a variety of clinical presentations such as nodules, ulcers, tenosynovitis, or nodular lymphangitis. 1,2 This water-borne organism is found both in naturally occurring bodies of water and in still or stagnant water, such as swimming pools and fish tanks, 1 leading to the names swimming pool granuloma and fish tank granuloma. 2,3 Infection usually occurs after direct inoculation through broken skin on exposure to fresh water or saltwater or after injuries from fish spines or oyster shells. The incubation period of M. marinum is typically between 2 and 4 weeks, 4,5 although incubation periods of more than 30 days have been reported. Pointed questions regarding skin injuries associated with water, fish, or shellfish may identify exposures that could otherwise be overlooked. The patient s reported exposure was more remote than the recognized incubation periods, and it is likely that another exposure occurred that she did not recall. The primary lesions of M. marinum are commonly described as superficial papules, nodules, plaques, ulcers, abscesses, or pustules occurring at the site of the injury. 1,6 These superficial lesions are emblematic of M. marinum infections, because 1338

4 Figure 3. Skin-Biopsy Specimen. A stain for acid-fast bacilli was positive (arrow). Figure 2. Magnetic Resonance Imaging of the Patient s Right Hand and Arm. There is inflammation (arrow) surrounding the flexor tendons in the wrist and forearm, as shown on the T 1 - weighted image. the pathogen typically does not invade beyond the superficial, cooler regions of the skin; it thrives at temperatures between 30 and 33 C rather than at the body s core temperature of 37 C. 7 In a large common-source outbreak of M. marinum infections that involved 290 patients, no cases of deep softtissue infections were reported. 8 However, there have been several reports of extension of infection into deep tissue, leading to tenosynovitis, arthritis, bursitis, or osteomyelitis, 9,10 and substantial associated morbidity, including risks of joint immobility and the need for amputation. The risks of untreated infection underscore the importance of timely diagnosis. Yet the nonspecific and often indolent presentation of M. marinum infection can make the diagnosis elusive. A detailed investigation of exposure history and culture or histopathological analysis of tissue are critical. The positive tuberculin skin test provided an important clue in the present case. The tuberculin skin test may be positive in patients with prior vaccination with M. bovis bacille Calmette Guérin (BCG) or exposure to environmental mycobacteria that share some of the antigens that are present in the tuberculin skin test. 11 If M. tuberculosis exposure is unlikely, as it was in this low-risk patient, a positive test should prompt careful consideration of other causes. IGRAs such as the QFT test and the enzymelinked immunospot assay use enzyme-linked immunosorbence to measure antigen-specific production of interferon by circulating T cells in whole blood. In a meta-analysis of 38 studies, IGRAs had a sensitivity of 78% (95% confidence interval, 73 to 82) for latent tuberculosis infection, which is similar to the reported sensitivity of the tuberculin skin test. The specificity was 97.0%, which is greater than that of the tuberculin skin test in patients with a history of BCG vaccination. 12 Neither test distinguishes between active tuberculosis and latent infection. Apart from the increased specificity, the main advantage of the IGRAs is that they require only a single patient visit. The Centers for Disease Control and Prevention has recommended that use of an IGRA be considered in any situation in which a tuberculin skin test is used. 13 The target antigens used in IGRAs are two proteins present in M. tuberculosis, early secretory antigenic target 6 (ESAT-6) and culture filtrate protein 10 (CFP-10). These proteins are also present 1339

5 in some other mycobacteria, including M. kansasii and M. marinum, but the diagnostic usefulness of the IGRAs has not been validated for these conditions, and they are not recommended for these diagnoses. A recent study showed that 7 of 12 patients with M. marinum infection (58%) had a positive IGRA. 14 This case also underscores the need to doggedly pursue the diagnostic standard in this case, confirmation by culture, especially since empirical therapy can be misguided. M. marinum is typically resistant to isoniazid, and this agent was discontinued in favor of combination therapy with clarithromycin and ethambutol, two first-line drugs associated with excellent outcomes. 4 Multiple biopsies were performed in this patient before surgically acquired samples finally yielded positive results. This is not unusual, since the number of organisms present is usually small. Smears for acid-fast bacilli are negative in up to 95% of tissue-biopsy specimens. 15 Under appropriate conditions, mycobacterial culture is positive in approximately 80% of cases of infection. M. marinum, however, grows optimally at a temperature between 30 and 33 C. Unless the laboratory automatically processes skin and soft-tissue specimens at these lower temperatures for nontuberculous mycobacteria, failure to indicate the possibility of M. marinum on the initial request form frequently results in false negative results from tissue cultured at 37 C. Cultures must be held for at least 6 weeks before one can conclude that the results are negative, since M. marinum, like many other mycobacteria, is a slow-growing organism. 4 Despite the substantial delay in proper identification of the infection, our patient did well after surgical débridement. After several months of treatment with first-line agents for M. marinum, her lesions which ended up being more than just skin deep fortunately resolved. Supported by grants from Chimerix (to the University of Michigan Medical School). Dr. Kaul reports receiving payments for expert testimony, review of malpractice cases, and insurance company evaluations; and Dr. Saint, payment as an advisory board member of Doximity. No other potential conflict of interest relevant to this article was reported. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org. References 1. Hautmann G, Lotti T. Atypical mycobacterial infections of the skin. Dermatol Clin 1994;12: Kullavanijaya P, Sirimachan S, Bhuddhavudhikrai P. Mycobacterium marinum cutaneous infections acquired from occupations and hobbies. Int J Dermatol 1993; 32: Fisher AA. Swimming pool granulomas due to Mycobacterium marinum: an occupational hazard of lifeguards. Cutis 1988;41: Gluckman SJ. Mycobacterium marinum. Clin Dermatol 1995;13: Kostman JR, DiNubile MJ. Nodular lymphangitis: a distinctive but often unrecognized syndrome. Ann Intern Med 1993;118: Bhambri S, Bhambri A, Del Rosso JQ. Atypical mycobacterial cutaneous infections. Dermatol Clin 2009;27: Silcox VA, David HL. Differential identification of Mycobacterium kansasii and Mycobacterium marinum. Appl Microbiol 1971;21: Philpott JA Jr, Woodburne AR, Philpott OS, Schaefer WB, Mollohan CS. Swimming pool granuloma: a study of 290 cases. Arch Dermatol 1963;88: Collins RJ, Chow SP, Ip FK, Leung YK. Synovial involvement by Mycobacterium marinum: a histopathological study of 25 culture-proven cases. Pathology 1988;20: Barton A, Bernstein RM, Struthers JK, O Neill TW. Mycobacterium marinum infection causing septic arthritis and osteomyelitis. Br J Rheumatol 1997;36: Huebner ES, Surawicz CM. Probiotics in the prevention and treatment of gastrointestinal infections. Gastroenterol Clin North Am 2006;35: Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;149: Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005;54:RR-15: [Erratum, MMWR Morb Mortal Wkly Rep 2005; 54:1288.] 14. Kobashi Y, Mouri K, Yagi S, et al. Clinical evaluation of the QuantiFERON-TB Gold test in patients with non-tuberculous mycobacterial disease. Int J Tuberc Lung Dis 2009;13: Prevost E, Walker EM Jr, Kreutner A Jr, Manos J. Mycobacterium marinum infections: diagnosis and treatment. South Med J 1982;75: Copyright 2012 Massachusetts Medical Society. clinical problem-solving series The Journal welcomes submissions of manuscripts for the Clinical Problem-Solving series. This regular feature considers the step-by-step process of clinical decision making. For more information, please see authors.nejm.org. 1340

Diagnosis Latent Tuberculosis. Disclosures. Case

Diagnosis Latent Tuberculosis. Disclosures. Case Diagnosis Latent Tuberculosis Neha Shah MD MPH Field Medical Officer Tuberculosis Control Branch California Department of Public Health Centers for Disease Control and Prevention September 2016 1 Disclosures

More information

CHAPTER 3: DEFINITION OF TERMS

CHAPTER 3: DEFINITION OF TERMS CHAPTER 3: DEFINITION OF TERMS NOTE: TB bacteria is used in place of Mycobacterium tuberculosis and Mycobacterium tuberculosis complex in most of the definitions presented here. 3.1 Acid-fast bacteria

More information

Christopher L. Hess, M.D., Bruce S. Wolock, M.D., and Michael S. Murphy, M.D.

Christopher L. Hess, M.D., Bruce S. Wolock, M.D., and Michael S. Murphy, M.D. CME Mycobacterium marinum Infections of the Upper Extremity Christopher L. Hess, M.D., Bruce S. Wolock, M.D., and Michael S. Murphy, M.D. Washington, D.C.; and Baltimore, Md. Learning Objectives: After

More information

Technical Bulletin No. 172

Technical Bulletin No. 172 CPAL Central Pennsylvania Alliance Laboratory QuantiFERON -TB Gold Plus Assay Contact: J Matthew Groeller, MPA(HCM), MT(ASCP), 717-851-4516 Operations Manager, Clinical Pathology, CPAL Jennifer Thebo,

More information

Approaches to LTBI Diagnosis

Approaches to LTBI Diagnosis Approaches to LTBI Diagnosis Focus on LTBI October 8 th, 2018 Michelle Haas, M.D. Associate Director Denver Metro Tuberculosis Program Denver Public Health DISCLOSURES I have no disclosures or conflicts

More information

TB Intensive Tyler, Texas December 2-4, 2008

TB Intensive Tyler, Texas December 2-4, 2008 TB Intensive Tyler, Texas December 2-4, 2008 Interferon Gamma Releasing Assays: Diagnosing TB in the 21 st Century Peter Barnes, MD December 2, 2008 TOPICS Use of interferon-gamma release assays (IGRAs)

More information

Tuberculosis Tools: A Clinical Update

Tuberculosis Tools: A Clinical Update Tuberculosis Tools: A Clinical Update CAPA Conference 2014 JoAnn Deasy, PA-C. MPH, DFAAPA jadeasy@sbcglobal.net Adjunct Faculty Touro PA Program Learning Objectives Outline the pathogenesis of active pulmonary

More information

Qualitative and quantitative results of interferon-γ release assays for monitoring the response to anti-tuberculosis treatment

Qualitative and quantitative results of interferon-γ release assays for monitoring the response to anti-tuberculosis treatment ORIGINAL ARTICLE Korean J Intern Med 217;32:32-38 https://doi.org/1.394/kjim.216.199 Qualitative and quantitative results of interferon-γ release assays for monitoring the response to anti-tuberculosis

More information

Peggy Leslie-Smith, RN

Peggy Leslie-Smith, RN Peggy Leslie-Smith, RN EMPLOYEE HEALTH DIRECTOR - AVERA TRAINING CONTENT 1. South Dakota Regulations 2. Iowa Regulations 3. Minnesota Regulations 4. Interferon Gamma Release Assay (IGRA)Testing 1 SOUTH

More information

PULMONARY MEDICINE BOARD REVIEW. Financial Conflicts of Interest. Question #1: Question #1 (Cont.): None. Christopher H. Fanta, M.D.

PULMONARY MEDICINE BOARD REVIEW. Financial Conflicts of Interest. Question #1: Question #1 (Cont.): None. Christopher H. Fanta, M.D. PULMONARY MEDICINE BOARD REVIEW Christopher H. Fanta, M.D. Pulmonary and Critical Care Division Brigham and Women s Hospital Partners Asthma Center Harvard Medical School Financial Conflicts of Interest

More information

Communicable Disease Control Manual Chapter 4: Tuberculosis

Communicable Disease Control Manual Chapter 4: Tuberculosis Provincial TB Services 655 West 12th Avenue Vancouver, BC V5Z 4R4 www.bccdc.ca Communicable Disease Control Manual Definitions Page 1 2.0 DEFINITIONS Many of the definitions that follow are taken from

More information

RESEARCH NOTE QUANTIFERON -TB GOLD IN-TUBE TEST FOR DIAGNOSING LATENT TUBERCULOSIS INFECTION AMONG CLINICAL-YEAR THAI MEDICAL STUDENTS

RESEARCH NOTE QUANTIFERON -TB GOLD IN-TUBE TEST FOR DIAGNOSING LATENT TUBERCULOSIS INFECTION AMONG CLINICAL-YEAR THAI MEDICAL STUDENTS Southeast Asian J Trop Med Public Health RESEARCH NOTE QUANTIFERON -TB GOLD IN-TUBE TEST FOR DIAGNOSING LATENT TUBERCULOSIS INFECTION AMONG CLINICAL-YEAR THAI MEDICAL STUDENTS Benjawan Phetsuksiri 1, Somchai

More information

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis What the Primary Physician Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Microbiology Epidemiology Common disease presentations Diagnosis of active

More information

Tuberculosis Update. Topics to be Addressed

Tuberculosis Update. Topics to be Addressed Tuberculosis Update Robert M. Jasmer, M.D. University of California, San Francisco TB Control Section, San Francisco Department of Public Health Topics to be Addressed TB in the USA Screening recommendations

More information

TB Prevention Who and How to Screen

TB Prevention Who and How to Screen TB Prevention Who and How to Screen 4.8.07. IUATLD 1st Asia Pacific Region Conference 2007 Dr Cynthia Chee Dept of Respiratory Medicine / TB Control Unit Tan Tock Seng Hospital, Singapore Cycle of Infection

More information

Mycobacterium Marinum Skin Infection

Mycobacterium Marinum Skin Infection Bahrain Medical Bulletin, Vol. 37, No. 2, June 2015 Mycobacterium Marinum Skin Infection Ahmed Anwar Aljowder, Bsc, MD* Azad Kareem Kassim, FRCPI, FRCP (Glasg), FAAD** Mazen Raees, MB, BCh, BAO, LRCP &

More information

TB Intensive San Antonio, Texas November 11 14, 2014

TB Intensive San Antonio, Texas November 11 14, 2014 TB Intensive San Antonio, Texas November 11 14, 2014 Interferon Gamma Release Assays Lisa Armitige, MD, PhD November 12, 2014 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict of

More information

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Randy Culpepper, MD, MPH Deputy Heath Officer/Medical Director Frederick County Health Department March 16, 2016 2 No

More information

PREVENTION OF TUBERCULOSIS. Dr Amitesh Aggarwal

PREVENTION OF TUBERCULOSIS. Dr Amitesh Aggarwal PREVENTION OF TUBERCULOSIS Dr Amitesh Aggarwal 25 to 50 % of persons exposed to intimate contact with active PTB - latent infection with TB. Exposure to index case for 12 hours - high risk of infection.

More information

Tuberculosis (TB) Fundamentals for School Nurses

Tuberculosis (TB) Fundamentals for School Nurses Tuberculosis (TB) Fundamentals for School Nurses June 9, 2015 Kristin Gall, RN, MSN/Pat Infield, RN-TB Program Manager Marsha Carlson, RN, BSN Two Rivers Public Health Department Nebraska Department of

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Tuberculosis prevention in immunodepressed patients M. Carmen Fariñas Álvarez Infectious Diseases.H.U.Marqués de Valdecilla University of Cantabria, Spain DISCLOSURES I have no potential conflicts with

More information

A Clinician s Perspective: Improving Rheumatology Patient Care Using the T-SPOT.TB Test

A Clinician s Perspective: Improving Rheumatology Patient Care Using the T-SPOT.TB Test A Clinician s Perspective: Improving Rheumatology Patient Care Using the T-SPOT.TB Test Solomon Forouzesh, MD, FACD, FACR Medical Director Arthritis Care & Treatment Center Clinical Associate Professor

More information

TB in Corrections Phoenix, Arizona

TB in Corrections Phoenix, Arizona TB in Corrections Phoenix, Arizona March 24, 2011 Treatment of Latent TB Infection Renuka Khurana MD, MPH March 24, 2011 Renuka Khurana, MD, MPH has the following disclosures to make: No conflict of interests

More information

Medical Bacteriology- Lecture 10. Mycobacterium. Actinomycetes. Nocardia

Medical Bacteriology- Lecture 10. Mycobacterium. Actinomycetes. Nocardia Medical Bacteriology- Lecture 10 Mycobacterium Actinomycetes Nocardia 1 Mycobacterium Characteristics - Large, very weakly gram positive rods - Obligate aerobes, related to Actinomycetes - Catalase positive

More information

TB Intensive Houston, Texas October 15-17, 2013

TB Intensive Houston, Texas October 15-17, 2013 TB Intensive Houston, Texas October 15-17, 2013 Interferon Gamma Release Assays (IGRA s) Lisa Armitige, MD, PhD October 16, 2013 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict

More information

TUBERCULOSIS IN HEALTHCARE SETTINGS Diana M. Nilsen, MD, FCCP Director of Medical Affairs, Bureau of Tuberculosis Control New York City Department of

TUBERCULOSIS IN HEALTHCARE SETTINGS Diana M. Nilsen, MD, FCCP Director of Medical Affairs, Bureau of Tuberculosis Control New York City Department of TUBERCULOSIS IN HEALTHCARE SETTINGS Diana M. Nilsen, MD, FCCP Director of Medical Affairs, Bureau of Tuberculosis Control New York City Department of Health and Mental Hygiene TODAY S PRESENTATION Epidemiology

More information

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Diagnosis of active TB Screening

More information

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB What the Primary Physician Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Common disease presentations Diagnosis of active TB Screening

More information

KJLM. Serial Interferon-gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection in Patients Treated with Immunosuppressive Agents

KJLM. Serial Interferon-gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection in Patients Treated with Immunosuppressive Agents Korean J Lab Med 2011;31:271-278 Original Article Diagnostic Immunology KJLM Serial Interferon-gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection in Patients Treated with Immunosuppressive

More information

Interferon Gamma Release Assay Testing for Latent Tuberculosis Infection: Physician Guidelines

Interferon Gamma Release Assay Testing for Latent Tuberculosis Infection: Physician Guidelines Interferon Gamma Release Assay Testing for Latent Tuberculosis Infection: Physician Guidelines Historically, Latent Tuberculosis Infection (LTBI) diagnosis was based on risk assessment, chest x-ray (CXR)

More information

Targeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease

Targeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease Self-Study Study Modules on Tuberculosis Targeted Testing and the Diagnosis of Latent Tuberculosis Infection and Tuberculosis Disease 1 Module 3: Objectives At completion of this module, learners will

More information

Abscess. A abscess is a localized collection of pus in the skin and may occur on any skin surface and be formed in any part of body.

Abscess. A abscess is a localized collection of pus in the skin and may occur on any skin surface and be formed in any part of body. Abscess A abscess is a localized collection of pus in the skin and may occur on any skin surface and be formed in any part of body. Ethyology Bacteria causing cutaneous abscesses are typically indigenous

More information

Evaluation and Treatment of TB Contacts Tyler, Texas April 11, 2014

Evaluation and Treatment of TB Contacts Tyler, Texas April 11, 2014 Evaluation and Treatment of TB Contacts Tyler, Texas April 11, 2014 Interferon Gamma Release Assays: Understanding the Test David Griffith, BA, MD April 11, 2014 David Griffith, BA, MD has the following

More information

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

TB Nurse Case Management San Antonio, Texas July 18 20, 2012 TB Nurse Case Management San Antonio, Texas July 18 20, 2012 IGRA s and Their Use in TB Nurse NCM Lisa Armitige, MD, PhD July 18, 2012 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict

More information

Standardized Case Definition for Extrapulmonary Nontuberculous Mycobacteria Infections

Standardized Case Definition for Extrapulmonary Nontuberculous Mycobacteria Infections Operational Guidance for Position Statement 17 ID 07: Standardized Case Definition for Extrapulmonary Nontuberculous Mycobacteria Infections Submission Date: April 28, 2017 Committee: Infectious Disease

More information

T-CELL RESPONSES ASSESSED USING IGRA AND TST ARE NOT CORRELATED WITH AFB GRADE AND CHEST RADIOGRAPH IN PULMONARY TUBERCULOSIS PATIENTS

T-CELL RESPONSES ASSESSED USING IGRA AND TST ARE NOT CORRELATED WITH AFB GRADE AND CHEST RADIOGRAPH IN PULMONARY TUBERCULOSIS PATIENTS T-CELL RESPONSES ASSESSED USING IGRA AND TST ARE NOT CORRELATED WITH AFB GRADE AND CHEST RADIOGRAPH IN PULMONARY TUBERCULOSIS PATIENTS Kiatichai Faksri 1, 4, Wipa Reechaipichitkul 2, 4, Wilailuk Pimrin

More information

Acute miliary tuberculosis in a five-month-old boy

Acute miliary tuberculosis in a five-month-old boy Hong Kong J. Dermatol. Venereol. (2007) 15, 138-142 Case Report Acute miliary tuberculosis in a five-month-old boy FC Ip and KC Lee A five-month-old boy presented with fever and multiple cutaneous papular

More information

Effect of prolonged incubation time on the results of the QuantiFERON TB Gold In-Tube assay for the diagnosis of latent tuberculosis infection

Effect of prolonged incubation time on the results of the QuantiFERON TB Gold In-Tube assay for the diagnosis of latent tuberculosis infection CVI Accepts, published online ahead of print on 3 July 2013 Clin. Vaccine Immunol. doi:10.1128/cvi.00290-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 3 Effect of prolonged

More information

LATENT TUBERCULOSIS. Robert F. Tyree, MD

LATENT TUBERCULOSIS. Robert F. Tyree, MD LATENT TUBERCULOSIS Robert F. Tyree, MD 1 YK TB OFFICERS Ron Bowerman Elizabeth Roll Mien Chyi (Pediatrics) Cindi Mondesir (Pediatrics) The new guys: Philip Johnson Robert Tyree 2009 CDC TB CASE DEFINITION

More information

Disseminated cutaneous BCG infection following BCG immunotherapy in patients with lepromatous leprosy

Disseminated cutaneous BCG infection following BCG immunotherapy in patients with lepromatous leprosy Lepr Rev (2015) 86, 180 185 CASE REPORT Disseminated cutaneous BCG infection following BCG immunotherapy in patients with lepromatous leprosy GEETI KHULLAR*, TARUN NARANG*, KUSUM SHARMA**, UMA NAHAR SAIKIA***

More information

Latent TB, TB and the Role of the Health Department

Latent TB, TB and the Role of the Health Department Latent TB, TB and the Role of the Health Department Elaine Darnall, RN, BSN, CIC TB Nurse Consultant Illinois Dept of Public Health March 21, 2018 Elaine Darnall has disclosed that there is no actual or

More information

Factors Associated with Indeterminate and False Negative Results of QuantiFERON-TB Gold In-Tube Test in Active Tuberculosis

Factors Associated with Indeterminate and False Negative Results of QuantiFERON-TB Gold In-Tube Test in Active Tuberculosis http://dx.doi.org/10.4046/trd.2012.72.5.416 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2012;72:416-425 CopyrightC2012. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights

More information

Appendix C. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)

Appendix C. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Appendix C Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Since publication of the Recommendations for Counting Reported Tuberculosis Cases 1 in January 1977, numerous changes

More information

Refractory Hand Ulceration: A Case of Chronic Ulceration and Sporotrichoid Spread in a Fish Tank Hobbyist following Mycobacterium marinum Infection

Refractory Hand Ulceration: A Case of Chronic Ulceration and Sporotrichoid Spread in a Fish Tank Hobbyist following Mycobacterium marinum Infection 137 This is an Open Access article licensed under the terms of the Creative Commons Attribution- NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the

More information

Tuberculosis is the model of a disease that can only be

Tuberculosis is the model of a disease that can only be INVITED COMMENTARY The Race to Eliminate Tuberculosis Jason E. Stout Tuberculosis is a major cause of morbidity and mortality worldwide, but the number of cases is now lower than ever before, both in the

More information

TUBERCULOSIS. Presented By: Public Health Madison & Dane County

TUBERCULOSIS. Presented By: Public Health Madison & Dane County TUBERCULOSIS Presented By: Public Health Madison & Dane County What is Tuberculosis? Tuberculosis, or TB, is a disease caused by a bacteria called Mycobacterium tuberculosis. The bacteria can attack any

More information

Carpal Tunnel Release

Carpal Tunnel Release Carpal Tunnel Release Carpal tunnel syndrome is a condition in the hand and wrist caused by excessive pressure on the median nerve in the wrist. Compression of the nerve typically causes numbness and tingling

More information

Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010

Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010 Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010 What is Latent TB Infection (LTBI)? Traci Hadley, RN October 5, 2010 LTBI or TB Disease? Presented by : Traci Hadley, RN

More information

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection (LTBI) Lloyd Friedman, M.D. Milford Hospital Yale University

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection (LTBI) Lloyd Friedman, M.D. Milford Hospital Yale University Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection (LTBI) Lloyd Friedman, M.D. Milford Hospital Yale University Tuberculosis Estimates USA World Infection 15,000,000 2,000,000,000

More information

An Unintended Consequence

An Unintended Consequence T h e n e w e ng l a nd j o u r na l o f m e dic i n e clinical problem-solving An Unintended Consequence Nasia Safdar, M.D., Cybele L. Abad, M.D., Daniel R. Kaul, M.D., David Jarrard, M.D., and Sanjay

More information

Rule out pulmonary tuberculosis: Clinical and radiographic clues for the internist

Rule out pulmonary tuberculosis: Clinical and radiographic clues for the internist REVIEW CME CREDIT EDUCATIONAL OBJECTIVE: Readers will recognize the signs of and include it in the differential diagnosis in appropriate scenarios CATHERINE ANNE CURLEY, MD Division Director, Hospital

More information

Clinical Utility of the QuantiFERON TB-2G Test for Elderly Patients With Active Tuberculosis*

Clinical Utility of the QuantiFERON TB-2G Test for Elderly Patients With Active Tuberculosis* CHEST Clinical Utility of the QuantiFERON -2G Test for Elderly Patients With Active Tuberculosis* Yoshihiro Kobashi, MD, PhD; Keiji Mouri, MD; Shinich Yagi, MD; Yasushi Obase, MD, PhD; Naoyuki Miyashita,

More information

Appendix B. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)

Appendix B. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Appendix B Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Since publication of the Recommendations for Counting Reported Tuberculosis Cases 1 in January 1977, numerous changes

More information

Introduction. Paronychia. Hand Infections. Eponychium. Paronychia 1/26/2015. INFECTIONS OF THE UPPER EXTREMITY Mark Rekant M.D.

Introduction. Paronychia. Hand Infections. Eponychium. Paronychia 1/26/2015. INFECTIONS OF THE UPPER EXTREMITY Mark Rekant M.D. Introduction INFECTIONS OF THE UPPER EXTREMITY Mark Rekant M.D. Thomas Jefferson University Philadelphia Hand Center South Jersey Hand Center Hand infections are frequent Taking into account the countless

More information

A Vietnamese woman with a 2-week history of cough

A Vietnamese woman with a 2-week history of cough Delphine Natali 1, Hai Tran Pham 1, Hung Nguyen The 2 delphinenatali@gmail.com Case report A Vietnamese woman with a 2-week history of cough A 52-year-old nonsmoker Vietnamese woman without any past medical

More information

Coordinating with Public Health on Tuberculosis Testing & Treatment

Coordinating with Public Health on Tuberculosis Testing & Treatment Coordinating with Public Health on Tuberculosis Testing & Treatment Bernadette Jakeman, PharmD, PhC, BCPS, AAHIVP Associate Professor University of New Mexico College of Pharmacy Objectives 1. Identify

More information

CUSOM Student Health Immunization Requirements

CUSOM Student Health Immunization Requirements CUSOM Student Health Immunization Requirements Regulatory and legislative authorities require that students demonstrate immunization, immunity and/or protection from multiple contagious diseases before

More information

Tuberculosis Facts. TB is not spread by: Sharing food and drink Shaking someone s hand Touching bed lines or toilet seats

Tuberculosis Facts. TB is not spread by: Sharing food and drink Shaking someone s hand Touching bed lines or toilet seats Tuberculosis Facts Below are frequently asked questions about TB, and their answers. If you have additional questions you may contact the City of Ennis Department of Health Services at 972-875-1234 or

More information

Proposed Regs.pdf

Proposed Regs.pdf Kansas Wesleyan University TB testing Policy In Compliance with Kansas Statue KSA 2009 Supp. 65-129, all Kansas Wesleyan University students who have traveled, resided in for more than three months, or

More information

Latent TB Infection (LTBI)

Latent TB Infection (LTBI) Latent TB Infection (LTBI) Diagnosis & Treatment of Latent TB Infection (LTBI) Amee Patrawalla MD MPH Assistant Professor UMDNJ-New Jersey Medical School Infection with Mycobacterium tuberculosis without

More information

Making the Diagnosis of Tuberculosis

Making the Diagnosis of Tuberculosis Making the Diagnosis of Tuberculosis Alfred Lardizabal, MD NJMS Global Tuberculosis Institute Testing for TB Infection Targeted Testing: Key Points Test only if plan for ensuring treatment De-emphasizes

More information

ORIGINAL ARTICLE. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients

ORIGINAL ARTICLE. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients ERJ Express. Published on July 25, 2007 as doi: 10.1183/09031936.00040007 ORIGINAL ARTICLE Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients Yoshihiro Kobashi, Keiji Mouri, Yasushi

More information

Student Health Requirements Master of Arts, Biomedical Sciences Program

Student Health Requirements Master of Arts, Biomedical Sciences Program Student Health Requirements Master of Arts, Biomedical Sciences Program All students in medically related programs, just as physicians in practice, are required to be current with required immunizations

More information

Self-Study Modules on Tuberculosis

Self-Study Modules on Tuberculosis Self-Study Modules on Tuberculosis Targe te d Te s ting and the Diagnosis of Latent Tuberculosis Infection and Tuberculosis Disease U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control

More information

Let s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year

Let s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year Madhukar Pai, MD, PhD Author and Series Editor Camilla Rodrigues, MD co-author Abstract Most individuals who get exposed

More information

Mycobacterium marinum Infection of the Hand in an Immunocompromised Aquarium Hobbyist

Mycobacterium marinum Infection of the Hand in an Immunocompromised Aquarium Hobbyist 2017;25(1):67-71 CASE REPORT Mycobacterium marinum Infection of the Hand in an Immunocompromised Aquarium Hobbyist Paola Đurinec 1, Jaka Radoš 1, Vera Katalinić-Janković 2, Ines Lakoš Jukić 1, Krešimir

More information

Identifying TB co-infection : new approaches?

Identifying TB co-infection : new approaches? Identifying TB co-infection : new approaches? Charoen Chuchottaworn MD. Senior Medical Advisor, Central Chest Institute of Thailand, Department of Medical Services, MoPH Primary tuberculosis Natural history

More information

EPI Case Study 2: Reliability, Validity, and Tests of Agreement in M. Tuberculosis Screening Time to Complete Exercise: 30 minutes

EPI Case Study 2: Reliability, Validity, and Tests of Agreement in M. Tuberculosis Screening Time to Complete Exercise: 30 minutes EPI Case Study 2: Reliability, Validity, and Tests of Agreement in M. Tuberculosis Time to Complete Exercise: 30 minutes LEARNING OBJECTIVES At the completion of this Case Study, participants should be

More information

Repeated tuberculin skin testing following therapy with TNF-alpha inhibitors

Repeated tuberculin skin testing following therapy with TNF-alpha inhibitors Clin Rheumatol (2009) 28:167 172 DOI 10.1007/s10067-008-1007-9 ORIGINAL ARTICLE Repeated tuberculin skin testing following therapy with TNF-alpha inhibitors Inbal Fuchs & Lone Avnon & Tamar Freud & Mahmoud

More information

Table 9. Policy for Tuberculosis Surveillance and Screening

Table 9. Policy for Tuberculosis Surveillance and Screening Policy for Tuberculosis Surveillance and Screening Purpose: to identify active cases of tuberculosis or latent TB among residents and staff of the nursing home in order to prevent transmission in this

More information

Fish Tank Exposure and Cutaneous Infections Due to Mycobacterium marinum: Tuberculin Skin Testing, Treatment, and Prevention

Fish Tank Exposure and Cutaneous Infections Due to Mycobacterium marinum: Tuberculin Skin Testing, Treatment, and Prevention MAJOR ARTICLE Fish Tank Exposure and Cutaneous Infections Due to Mycobacterium marinum: Tuberculin Skin Testing, Treatment, and Prevention Felicia M. T. Lewis, Bryan J. Marsh, and C. Fordham von Reyn Infectious

More information

LESSON ASSIGNMENT. After completing this lesson, you should be able to:

LESSON ASSIGNMENT. After completing this lesson, you should be able to: LESSON ASSIGNMENT LESSON 6 Tuberculosis. TEXT ASSIGNMENT Paragraphs 6-1 through 6-11. LESSON OBJECTIVES After completing this lesson, you should be able to: 6-1. Identify the characteristics, signs/ symptoms,

More information

Contracts Carla Chee, MHS May 8, 2012

Contracts Carla Chee, MHS May 8, 2012 Moving Past the Basics of Tuberculosis Phoenix, Arizona May 8-10, 2012 Contracts Carla Chee, MHS May 8, 2012 Carla Chee, MHS has the following disclosures to make: No conflict of interests No relevant

More information

Medical Bacteriology- lecture 13. Mycobacterium Actinomycetes

Medical Bacteriology- lecture 13. Mycobacterium Actinomycetes Medical Bacteriology- lecture 13 Mycobacterium Actinomycetes Mycobacterium tuberculosis Large, very weakly gram positive rods, Obligate aerobes, related to Actinomycetes, non spore forming, non motile

More information

Revised Technical Instructions for Civil Surgeons. October 9, 2018

Revised Technical Instructions for Civil Surgeons. October 9, 2018 Revised Technical Instructions for Civil Surgeons October 9, 2018 Speakers Joanna Regan Centers for Disease Control and Prevention Shereen Katrak California Department of Public Health Pennan Barry California

More information

2/18/19. Case 1. Question

2/18/19. Case 1. Question Case 1 Which of the following can present with granulomatous inflammation? A. Sarcoidosis B. Necrobiotic xanthogranulma C. Atypical mycobacterial infection D. Foreign Body Reaction E. All of the above

More information

Use of an Interferon- Release Assay To Diagnose Latent Tuberculosis Infection in Foreign-Born Patients*

Use of an Interferon- Release Assay To Diagnose Latent Tuberculosis Infection in Foreign-Born Patients* Original Research MYCOBACTERIAL DISEASE Use of an Interferon- Release Assay To Diagnose Latent Tuberculosis Infection in Foreign-Born Patients* Daniel Brodie, MD; David J. Lederer, MD, MS; Jade S. Gallardo,

More information

Comparison of Quantiferon-TB Gold With Tuberculin Skin Test for Detecting Latent Tuberculosis Infection Prior to Liver Transplantation

Comparison of Quantiferon-TB Gold With Tuberculin Skin Test for Detecting Latent Tuberculosis Infection Prior to Liver Transplantation American Journal of Transplantation 2007; 7: 2797 2801 Blackwell Munksgaard C 2007 The Authors Journal compilation C 2007 The American Society of Transplantation and the American Society of Transplant

More information

Evaluation of an In Vitro Assay for Gamma Interferon Production in Response to Mycobacterium tuberculosis Infections

Evaluation of an In Vitro Assay for Gamma Interferon Production in Response to Mycobacterium tuberculosis Infections CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Nov. 2004, p. 1089 1093 Vol. 11, No. 6 1071-412X/04/$08.00 0 DOI: 10.1128/CDLI.11.6.1089 1093.2004 Copyright 2004, American Society for Microbiology. All

More information

2016 OPAM Mid-Year Educational Conference, Sponsored by AOCOPM Sunday, March 13, 2016

2016 OPAM Mid-Year Educational Conference, Sponsored by AOCOPM Sunday, March 13, 2016 Learning Objectives Tuberculosis Case Discussions: Evaluation for Tuberculosis Infection Melissa C. Overman, DO, MPH, CHES, FAOCOPM Describe appropriate technique for TST placement, reading and interpretation

More information

Multiple Skin Colored Nodules on both Legs in Patient with Positive QuantiFERON R -TB Gold Test

Multiple Skin Colored Nodules on both Legs in Patient with Positive QuantiFERON R -TB Gold Test pissn 1013-9087ㆍeISSN 2005-3894 Ann Dermatol Vol. 29, No. 1, 2017 https://doi.org/10.5021/ad.2017.29.1.95 CASE REPORT Multiple Skin Colored Nodules on both Legs in Patient with Positive QuantiFERON R -TB

More information

Barbara J Seaworth MD Medical Director, Heartland National TB Center Professor, Internal Medicine and Infectious Disease UT Health Northeast

Barbara J Seaworth MD Medical Director, Heartland National TB Center Professor, Internal Medicine and Infectious Disease UT Health Northeast Practical Aspects for Using the Interferon Gamma Release Assay (IGRA) Test Live Webinar July 14, 2017 Barbara J Seaworth MD Medical Director, Heartland National TB Center Professor, Internal Medicine and

More information

A Rare case of Tubercular Gingivitis Case Report

A Rare case of Tubercular Gingivitis Case Report Case Report A Rare case of Tubercular Gingivitis Case Report *Dr. Ansh Chugh 1, Dr. Firoz A Hakkim 2, Dr. Rajesh. V 3, Dr. Raghava Sharma 4 1: JUNIOR RESIDENT IN GENERAL MEDICINE 2: SENIOR RESIDENT IN

More information

Community pharmacy-based tuberculosis skin testing

Community pharmacy-based tuberculosis skin testing Community pharmacy-based tuberculosis skin testing Shanna K. O Connor, PharmD ISU KDHS Spring CE Seminar 2018 In support of improving patient care, Idaho State University Kasiska Division of Health Sciences

More information

A 40-year old male with follicular papule and pustule at central face area for 3 months

A 40-year old male with follicular papule and pustule at central face area for 3 months A 40-year old male with follicular papule and pustule at central face area for 3 months GMS- Neg AFB-Neg Fite stain - neg HISTOPATHOLOGICAL DIFFERENTIAL DIAGNOSIS CASEOUS GRANULOMA INFECTION -MYCOBACTERIUM

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE TB Partial Update Appendix 1 - Scope NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Tuberculosis: interferon gamma tests for the diagnosis of latent tuberculosis (partial

More information

The Prevalence Rate of Tuberculin Skin Test Positive by Contacts Group to Predict the Development of Active Tuberculosis After School Outbreaks

The Prevalence Rate of Tuberculin Skin Test Positive by Contacts Group to Predict the Development of Active Tuberculosis After School Outbreaks ORIGINAL ARTICLE http://dx.doi.org/10.4046/trd.2015.78.4.349 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2015;78:349-355 The Prevalence Rate of Tuberculin Skin Test Positive by Contacts

More information

JCM Version 3. Utilization of the QuantiFERON-TB Gold Test in a 2-Step Process with the

JCM Version 3. Utilization of the QuantiFERON-TB Gold Test in a 2-Step Process with the JCM Accepts, published online ahead of print on 23 June 2010 J. Clin. Microbiol. doi:10.1128/jcm.02253-09 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients

Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients Eur Respir J 2007; 30: 945 950 DOI: 10.1183/09031936.00040007 CopyrightßERS Journals Ltd 2007 Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients Y. Kobashi, K. Mouri, Y. Obase,

More information

Clinical Policy Title: Interferon-gamma release assays for tuberculosis screening

Clinical Policy Title: Interferon-gamma release assays for tuberculosis screening Clinical Policy Title: Interferon-gamma release assays for tuberculosis screening Clinical Policy Number: 07.01.06 Effective Date: March 1, 2014 Initial Review Date: November 20, 2013 Most Recent Review

More information

Tuberculosis testing: Which patients, which test?

Tuberculosis testing: Which patients, which test? Tuberculosis testing: Which patients, which test? The most appropriate test to identify latent TB depends on the patient s risk for developing active TB and other factors. This review provides practical

More information

Case Report Diagnostic Challenges of Tuberculous Lymphadenitis Using Polymerase Chain Reaction Analysis: A Case Study

Case Report Diagnostic Challenges of Tuberculous Lymphadenitis Using Polymerase Chain Reaction Analysis: A Case Study Case Reports in Infectious Diseases Volume 2015, Article ID 723726, 4 pages http://dx.doi.org/10.1155/2015/723726 Case Report Diagnostic Challenges of Tuberculous Lymphadenitis Using Polymerase Chain Reaction

More information

Chapter 4 Diagnosis of Tuberculosis Disease

Chapter 4 Diagnosis of Tuberculosis Disease Chapter 4 Diagnosis of Tuberculosis Disease Table of Contents Chapter Objectives.... 75 Introduction.... 77 Medical Evaluation.......................................................... 78 Chapter Summary...

More information

New Approaches to the Diagnosis and Management of Tuberculosis Infection in Children and Adolescents

New Approaches to the Diagnosis and Management of Tuberculosis Infection in Children and Adolescents New Approaches to the Diagnosis and Management of Tuberculosis Infection in Children and Adolescents Jeffrey R. Starke, M.D. Professor of Pediatrics Baylor College of Medicine [With great thanks to Andrea

More information

Sharing the Care: Working Together on LTBI Treatment and Management Webinar. September 24, Curry International Tuberculosis Center

Sharing the Care: Working Together on LTBI Treatment and Management Webinar. September 24, Curry International Tuberculosis Center TB Infection Diagnostics and Treatment Neha Shah MD MPH Field Medical Officer Tuberculosis Control Branch California Department of Public Health Centers for Disease Control and Prevention 1 Curry International

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Tuberculosis: interferon gamma tests for the diagnosis of latent tuberculosis (partial update) 1.1 Short title Tuberculosis

More information

Using Interferon Gamma Release Assays for Diagnosis of TB Infection

Using Interferon Gamma Release Assays for Diagnosis of TB Infection Learning Objectives Using Interferon Gamma Release Assays for Diagnosis of TB Infection 1. Describe available Interferon Gamma Release Assay tests for TB infection and how they work. 2. Understand interpretation

More information

Diagnosis and Medical Management of Latent TB Infection

Diagnosis and Medical Management of Latent TB Infection Diagnosis and Medical Management of Latent TB Infection Marsha Majors, RN September 7, 2017 TB Contact Investigation 101 September 6 7, 2017 Little Rock, AR EXCELLENCE EXPERTISE INNOVATION Marsha Majors,

More information

Latent tuberculosis (TB) infection (LTBI), a

Latent tuberculosis (TB) infection (LTBI), a COMMENTARY Time for a change? Updated guidelines using interferon gamma release assays for detection of latent tuberculosis infection in the office setting Marisa Kardos, BS, and Alexa Boer Kimball, MD,

More information

Appendix B. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)

Appendix B. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Appendix B Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Since publication of the Recommendations for Counting Reported Tuberculosis Cases 1 in January 1977, numerous changes

More information